GLP vs. GPT

A conversation reveals a compelling perspective on the potential of GLP drugs compared to AI technologies like GPT. An early investor shares insights on the obesity crisis and the unique approach of a pharmaceutical company he backed years ago, leading to a surprising $3 billion exit. The discussion highlights the importance of recognizing emerging trends and innovative solutions in the health sector.